• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN SA Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Physicians May Overprescribe Antidepressants Based on Brief Depression Questionnaires

Physicians May Overprescribe Antidepressants Based on Brief Depression Questionnaires

October 1, 2014
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue

Subject:
Depression

Short Description:

Physicians May Overprescribe Antidepressants Based on Brief Depression Questionnaires

Background:

Brief depression screening questionnaires are popular, especially with primary care providers (PCPs). However, a new study suggests that PCPs who use these questionnaires might be prescribing antidepressants to patients who don’t need them.

This was a prospective study of patients at six primary care office locations in California. Each patient was administered the Patient Health Questionnaire-9 (PHQ-9) by the researchers immediately prior to a primary-care office visit. The PHQ-9 assesses how often respondents have experienced various symptoms (such as feeling down, sleep problems, thoughts of harming oneself) in the previous two weeks. Scores can range from 0 to 27. PHQ-9 results were not shared with the physicians.

For this study, the researchers focused on a specific population of 595 patients, those with a PHQ-9 score less than 10, since this group is considered to be at low risk for depression and poor candidates for taking antidepressants. In this group, most (545) did not complete a separate measure of depressive symptoms during their office visit. Very few of these patients were diagnosed with depression (10.5%), were recommended an antidepressant (1.6%), or were prescribed an antidepressant (3.8%). However, for those patients who were administered a brief depression symptom measure by their primary care provider, 20% were given a diagnosis of depression, 12% were recommended an antidepressant, and another 12% were prescribed an antidepressant.

Use of the screening measures, which was more common during office visits in HMO and Veterans Affairs settings, increased the likelihood that patients who were not likely to be depressed would receive depression treatment (odds ratio 3.2; 95% confidence interval 1.1-9.2). The study highlights the need for more research to determine the best way to use brief depression questionnaires in primary care practices, and to balance benefits and risks of treatment, including overdiagnosis of depression and the use of antidepressants (Jerant A et al, J Am Board Fam Med 2014;27(5);611–620).

TCPR’s Take: Most psychiatrists are aware that brief symptom measures are meant to be screening tools, not diagnostic instruments. Nevertheless, this study shows that in the primary care setting these questionnaires may provide the justification for a diagnosis of depression and the prescription of antidepressants to patients who are not clinically depressed. Without more evidence to support the use of screening instruments in primary care settings, this practice should be reconsidered.

General Psychiatry
KEYWORDS antidepressants research_updates
www.thecarlatreport.com
Issue Date: October 1, 2014
SUBSCRIBE NOW
Table Of Contents
Sunshine Linked to Suicide Rates
Research Indicates Schizophrenia is Eight Distinct Disorders
Pharmacogenetic Testing in Clinical Psychiatry
Belsomra: A New Hypnotic? Don’t Get Too Excited
The Uses of Pharmacogenetic Testing
Physicians May Overprescribe Antidepressants Based on Brief Depression Questionnaires
DOWNLOAD NOW
Featured Book
  • MFB6eCover.jpg

    Medication Fact Book for Psychiatric Practice, Sixth Edition (2022)

    Guidance, clinical pearls, and bottom-line assessments covering the medications you use in your...
    READ MORE
Featured Video
  • therapist_canstockphoto9201097.jpg
    General Psychiatry

    Using SAMe In Clinical Practice with Garrett Rossi, MD

    Read More
Featured Podcast
  • canstockphoto4921771.jpg
    General Psychiatry

    Psychopharm Commandment #6: MAOIs

    MAOIs rank high in efficacy and are pretty well tolerated too, as long as you watch for two critical interactions.

    Listen now
Recommended
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report

Contact

info@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2023 Carlat Publishing, LLC and Affiliates, All Rights Reserved.